top of page
For animal use only.
 
CHLAMYVAX is an inactivated bivalent vaccine for the active immunisation of healthy cattle, sheep and goats against enzootic abortion caused by Chlamydia abortus and a range o subclinical disease manifestations including infectious conjunctivitis, arthritis, infertility, enteritis, mastitis and reduced growth rates cause by Chlamydia pecorum.
 
COMPOSITION PER DOSE (1 ml)
CHLAMYVAX is an oil emulsion vaccine consisting of formalin-inactivated C. abortus and C. pecorum strains.
 
Each dose (1 ml) of CHLAMYVAX contains:
Inactivated C. abortus: ≥ 2,5 x 10⁵ TCID₅₀ per 1 ml dose
Inactivated C. pecorum: ≥ 2,5 x 10⁵ TCID₅₀ per 1 ml dose
 
STORAGE
Store and transport refrigerated between 2°C and 8°C. Do not freeze. Protect from light. Do not use after the expiry date printed on the container. Use immediately after opening the vial. Do not store any vils into which a needle or other device has been inserted, for future use.
 
DIRECTIONS FOR USE - USE ONLY AS DIRECTED
  • It is normal for CHLAMYVAX to develop a cream layer on top during storage. Simple inversion of the vial prior to injection is adequate to remix all components.
  • Inject animals subcutaneously on the side of the neck only. DO NOT deviate from the recommended route and injection site location.
  • Ensure that all animals are  vaccinated.
  • Administer a dose at least 4 weeks before the breeding season or during early pregnancy, before 60 days of gestation.
  • CHLAMYVAX is safe for use  during all stages of pregnancy.
  • In the face of an outbreak, animals may be vaccinated before lambing/calving, which reduces abortions and prevents excretion of the pathogenic micro-organism by infected pregnant animals.
  • Vaccination during an outbreak also protects heifers/ewes not previously vaccinated from becoming latently infected, thus resulting in fewer aborted animals for the following year.
  • It is critical to vaccinate replacement heifers/ewes as ell as newly purchased animals.
  • CHLAMYVAX may be used as a therapeutic vaccine targeted at subclinical chlamydial infections caused by C. pecorum during high risk outbreak periods. A long-term protective effect however requires frequent revaccination.
 
DOSAGE
  • Cattle: Inject 2 ml subcutaneously, on the side of the neck only. 
  • Sheep and goats: Inject 1 ml subcutaneously, on the side of the neck only. 
  • A booster vaccination of the above-mentioned doses for cattle, sheep and goats respectively is recommended 3-4 weeks later.
 
PACKING SIZE AND ORDERING CODE
100 ml (LVS06568)
 
Reg. no. G4535 (36/1947)
Reg. holder: Vetvax (Pty) Ltd, Reg. no. 2004/035302/07, 442 Rigel Avenue South, Erasmusrand, Pretoria | Tel. 012 349 2772

CHLAMYVAX

    • Withdrawal period: Do not slaughter animals for human consumption within 21 days of vaccination.
    • Vaccinate healthy animals only.
    • DO NOT mix with any other vaccine or immunological product.
    • Avoid direct contact with the product, to prevent self-injection, or contamination of the eyes or skin. If contact occurs, rinse affected area repeatedly with clean water. 
    • Accidental self-injection of the user may cause serious reactions. In case of accidental self-injection, seek medical advice immediately and show the package insert or label to the physician.
    • Do not over- or under-dose the vaccine.
    • Usually no marked reactions follow vaccination, although a transient swelling may appear at the site of inoculation, and some animals may show a moderate rise of temperature for one or two days.
    • Ensure that marketed animals do not have local reacions (swellings) at the site of vaccine administration, or elevated temperature reactions (fever) as this may result in the condemnation of the carcasses.
    • Do not use in animal species other than those indicated.
    • Do not administer to animals in poor or extremely poor body condition.
    • Do not inject intravenously.
    • KEEP OUT OF REACH OF CHILDREN, UNINFORMED PERSONS AND ANIMALS.
    • Although this product has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.
    • Follow aseptic procedures. Clean and sterilise all vaccination equipment (containers, syringes and needles) prior to and during use to prevent contaminating the contents of the vial.
    • Do not use the contents of damaged vials.
    • Wash and disinfect hands with a disinfectant after vaccination.
    • Do not use disinfectants or antiseptics to sterilize any equipment.
    • Wear protective clothing, masks, gloves etc. according to hazard standards.
    • Avoid contact with skin, eyes and mouth.
    • Do not eat, drink or smoke whilst handling the product.
    • Use the entire contents of the vial once opened. Do not store partially used containers for future use.
    • It is esential to adhere to the vaccination programme to maintain a satisfactory immune response.
    • Destroy any unused vaccine and dispose of all containers and disposable equipment after use, in accordance with the National Environmental Management: Waste Act (Act no. 59 of 2008).
    • Do not contaminate rivers, dams or any water sources with containers or waste.
    • Local reactions may occur in some animals at the injection site. They will disappear after a few days. If you notice any serious effects not mentioned here, please inform your veterinarian.
bottom of page